SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001625101-22-000059
Filing Date
2022-08-10
Accepted
2022-08-10 16:15:23
Documents
13
Period of Report
2022-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20220810x8k.htm   iXBRL 8-K 76418
2 EX-99.1 plse-20220810xex99_1.htm EX-99.1 386608
  Complete submission text file 0001625101-22-000059.txt   601132

Data Files

Seq Description Document Type Size
3 EX-101.SCH plse-20220810.xsd EX-101.SCH 2659
4 EX-101.LAB plse-20220810_lab.xml EX-101.LAB 14512
5 EX-101.PRE plse-20220810_pre.xml EX-101.PRE 10363
7 EXTRACTED XBRL INSTANCE DOCUMENT plse-20220810x8k_htm.xml XML 4625
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 221151999
SIC: 3841 Surgical & Medical Instruments & Apparatus